The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification
Open accessAbstract
Introduction.Macrolide, lincosamide, and streptogramin (MLS) antibiotics are chemically distinct but have a similar mode of action.They have a narrow spectrum of activity that includes gram-positive cocci (in particular, staphylo- cocci, streptococci, and enterococci) and bacilli and gram- negative cocci.These drugs, especially clindamycin, are also potent against anaerobic bacteria.Gram-negative bacilli are usually resistant to MLS antibiotics, but certain enteric bacilli and Haemophilus spp.are susceptible to azithromy- cin in vitro.However, the activities of these antibiotics against Campylobacter, Legionella, and Chlamydia spp.are at the origin of the recent renaissance of erythromycin.Macrolides are composed of a minimum of two amino and/or neutral sugars attached to a lactone ring of variable size.Macrolides commercially available or in clinical devel- opment can be divided into 14-, 15-, and 16-membered lactone ring macrolides.These classes differ in their phar- macokinetic properties and in their responses to bacterial resistance mechanisms.Lincosamides (lincomycin and the more active semisynthetic derivative clindamycin) are alkyl derivatives of proline and are devoid of a lactone ring.Streptogramin antibiotics are used in clinical practice in certain countries, including Belgium and France.They are composed of two factors, A and B (II and I in pristinamycin and M and S in virginiamycin, respectively), that act in synergy and are produced by the same microorganism.In 1956, a few years after the introduction of erythromycin in therapy, resistance of staphylococci to this drug emerged and subsequently spread in France, the United Kingdom, and the United States (13,22,37).The MLS cross-resistance phenotype due to modification of the drug target is widely distributed and has, since then, been detected in Staphylo- coccus spp.(41, 72), Streptococcus spp.(18, 23, 30), Entero- coccus spp.(16), Corynebacterium diptheriae (17), Bacteroides spp.(61, 65), Clostridium spp.(64, 79), Bacillus spp.(47, 48), Lactobacillus spp.(5, 57), Mycoplasma pneumoniae (69), Campylobacter spp.(11) and, recently, Propionibacte- rium spp.(20) and members of the family Enterobac- teriaceae (1).This paper reviews the biochemical mechanism and the genetic basis of resistance to MLS antibiotics in human pathogens by target modification.Biochemical mechanism.Clinical isolates resistant to erythromycin synthesize an enzyme that N6 dimethylates an adenine residue in 23S rRNA (40).The precise site of
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jacob, A. E., & Hobbs, S. J. (1974) · Journal of Bacteriology · doi:10.1128/jb.117.2.360-372.1974 · Cited by 677
Altered Methylation of Ribosomal RNA in an Erythromycin-Resistant Strain of Staphylococcus aureus
Lai, C. J., & Weisblum, B. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.856 · Cited by 274
Skinner, R., Cundliffe, E., & Schmidt, F. J. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44232-3 · Cited by 263
Horinouchi, S., & Weisblum, B. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.12.7079 · Cited by 262
Properties of erythromycin-inducible transposon Tn917 in Streptococcus faecalis
Tomich, P. K., An, F. Y., & Clewell, D. B. (1980) · Journal of Bacteriology · doi:10.1128/jb.141.3.1366-1374.1980 · Cited by 234
Penicillinase plasmids of Staphylococcus aureus: Restriction-deletion maps
Novick, R. P., Murphy, E., Gryczan, T. J., Baron, E., & Edelman, I. (1979) · Plasmid · doi:10.1016/0147-619x(79)90010-6 · Cited by 234
Leclercq, R., & Courvalin, P. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.7.1273 · Cited by 230
Self-citationTransposable multiple antibiotic resistance in Streptococcus pneumoniae
Courvalin, P., & Carlier, C. (1986) · Molecular and General Genetics MGG · doi:10.1007/bf00430441 · Cited by 216
Self-citationTransfer of Multiple Antibiotic Resistance between Subspecies of Bacteroides fragilis
Privitera, G., Dublanchet, A., & Sebald, M. (1979) · Journal of Infectious Diseases · doi:10.1093/infdis/139.1.97 · Cited by 206
Triple post‐transcriptional control
Bechhofer, D. H. (1990) · Molecular Microbiology · doi:10.1111/j.1365-2958.1990.tb02051.x · Cited by 204
Cited by
The crisis in antibiotic resistance
Neu, H. C. (1992) · Science · doi:10.1126/science.257.5073.1064 · Cited by 2,834
Inactivation of Antibiotics and the Dissemination of Resistance Genes
Davies, J. (1994) · Science · doi:10.1126/science.8153624 · Cited by 1,730
Detection of erythromycin-resistant determinants by PCR
Sutcliffe, J., Grebe, T., Tait-Kamradt, A., & Wondrack, L. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.11.2562 · Cited by 989
Nomenclature for Macrolide and Macrolide-Lincosamide-Streptogramin B Resistance Determinants
Roberts, M. C., Sutcliffe, J., Courvalin, P., Jensen, L. B., Rood, J., & Seppala, H. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.12.2823 · Cited by 874
Self-citationButaye, P., Devriese, L. A., & Haesebrouck, F. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.2.175-188.2003 · Cited by 712
Sutcliffe, J., Tait-Kamradt, A., & Wondrack, L. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.8.1817 · Cited by 619
Macrolide Resistance Conferred by Base Substitutions in 23S rRNA
Vester, B., & Douthwaite, S. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.1-12.2001 · Cited by 556
Lina, G., Quaglia, A., Reverdy, M.-E., Leclercq, R., Vandenesch, F., & Etienne, J. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1062 · Cited by 548
Self-citationBacterial efflux pump inhibitors from natural sources
Stavri, M., Piddock, L. J. V., & Gibbons, S. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl460 · Cited by 547
Molecular Detection of Antimicrobial Resistance
Fluit, A. C., Visser, M. R., & Schmitz, F.-J. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.836-871.2001 · Cited by 525
McGee, L., McDougal, L., Zhou, J., Spratt, B. G., Tenover, F. C., George, R., Hakenbeck, R., Hryniewicz, W., Lefévre, J. C., Tomasz, A., et al. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.7.2565-2571.2001 · Cited by 518
Mechanisms of bacterial biocide and antibiotic resistance: ANTIBIOTIC AND BIOCIDE RESISTANCE
Poole, K. (2002) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.92.5s1.8.x · Cited by 513
Aarestrup, F. M., Agerso, Y., Gerner–Smidt, P., Madsen, M., & Jensen, L. B. (2000) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(00)00130-9 · Cited by 486
Mart??nez-Aguilar, G., Avalos-Mishaan, A., Hulten, K., Hammerman, W., Mason, E. O., & Kaplan, S. L. (2004) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000133044.79130.2a · Cited by 416
Streptogramins, Oxazolidinones, and Other Inhibitors of Bacterial Protein Synthesis
Mukhtar, T. A., & Wright, G. D. (2005) · Chemical Reviews · doi:10.1021/cr030110z · Cited by 371
Use of antimicrobials in veterinary medicine and mechanisms of resistance
Schwarz, S., & Chaslus-Dancla, E. (2001) · Veterinary Research · doi:10.1051/vetres:2001120 · Cited by 370
SATTLER, C. A., MASON, E. O., & KAPLAN, S. L. (2002) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200210000-00005 · Cited by 332
Lonks, J. R., Garau, J., Gomez, L., Xercavins, M., Ochoa de Echagüen, A., Gareen, I. F., Reiss, P. T., & Medeiros, A. A. (2002) · Clinical Infectious Diseases · doi:10.1086/341978 · Cited by 324
Antibiotic Usage in Animals: Impact on Bacterial Resistance and Public Health
van den Bogaard, A. E., & Stobberingh, E. E. (1999) · Drugs · doi:10.2165/00003495-199958040-00002 · Cited by 318
MARTÍNEZ-AGUILAR, G., HAMMERMAN, W. A., MASON, E. O., & KAPLAN, S. L. (2003) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000073163.37519.ee · Cited by 315
Review of Macrolides and Ketolides: Focus on Respiratory Tract Infections
Zhanel, G. G., Dueck, M., Hoban, D. J., Vercaigne, L. M., Embil, J. M., Gin, A. S., & Karlowsky, J. A. (2001) · Drugs · doi:10.2165/00003495-200161040-00003 · Cited by 304
panX: pan-genome analysis and exploration
Ding, W., Baumdicker, F., & Neher, R. A. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx977 · Cited by 300
mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae
Tait-Kamradt, A., Clancy, J., Cronan, M., Dib-Hajj, F., Wondrack, L., Yuan, W., & Sutcliffe, J. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.10.2251 · Cited by 298
Emergence and management of drug-resistant enterococcal infections
Arias, C. A., & Murray, B. E. (2008) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.6.5.637 · Cited by 294
Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children
FRANK, A. L., MARCINAK, J. F., MANGAT, P. D., TJHIO, J. T., KELKAR, S., SCHRECKENBERGER, P. C., & QUINN, J. P. (2002) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200206000-00010 · Cited by 271
Singh, K. V., Weinstock, G. M., & Murray, B. E. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1845-1850.2002 · Cited by 263
“These organisms have acquired and/or intrinsic resistance to many different antibiotics (18, 19), which poses a serious problem for the treatment of patients infected with these organisms.”
BackgroundTait-Kamradt, A., Davies, T., Appelbaum, P. C., Depardieu, F., Courvalin, P., Petitpas, J., Wondrack, L., Walker, A., Jacobs, M. R., & Sutcliffe, J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3395-3401.2000 · Cited by 260
Self-citationA Novel Erythromycin Resistance Methylase Gene ( ermTR ) in Streptococcus pyogenes
Seppälä, H., Skurnik, M., Soini, H., Roberts, M. C., & Huovinen, P. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.2.257 · Cited by 258
Hershberger, E., Donabedian, S., Konstantinou, K., & Zervos, M. J. (2004) · Clinical Infectious Diseases · doi:10.1086/380125 · Cited by 156
Obana, N., Takada, H., Crowe-McAuliffe, C., Iwamoto, M., Egorov, A. A., Wu, K. J. Y., Chiba, S., Murina, V., Paternoga, H., Tresco, B. I. C., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad193 · Cited by 42
Choi, J., Rieke, E. L., Moorman, T. B., Soupir, M. L., Allen, H. K., Smith, S. D., & Howe, A. (2018) · FEMS Microbiology Ecology · doi:10.1093/femsec/fiy006 · Cited by 19
Mechanistic Basis for the Translation Inhibition of Cutibacterium acnes by Clindamycin
Lomakin, I. B., Devarkar, S. C., Grada, A., & Bunick, C. G. (2024) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2024.07.013 · Cited by 7
Metadata
- Authors
- Leclercq, R., & Courvalin, P.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1991-07
- Volume
- 35
- Issue
- 7
- Pages
- 1267-1272
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W1988907123
- Cited by
- 628
- References
- 48
- FWCI
- 6.85
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.